Previous 10 | Next 10 |
United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with pot...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The energy and shipping markets take center stage next week as the drama in the Suez Canal continues to play out and OPE...
United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , March 24, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced toda...
3D Systems has seen recovery with revenues growing by 2.6% compared to last year and 26.8% on a sequential basis respectively. Also, there was breakthrough in bio-printing, an innovation the company intends to use for boosting up sales, and one of the reasons Cathie Wood's ARKQ increm...
United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , March 9, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that...
United Therapeutics ([[UTHR]] -2.0%) is trading lower today after announcing its decision to discontinue the development of Trevyent (Treprostinil) due to written feedback received from the FDA in late February.The FDA comments have followed a meeting the company held on its planned...
United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care Conference PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Feb. 24, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today ...
United Therapeutics Corporation (UTHR) Q4 2020 Earnings Conference Call February 24, 2021, 09:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairman and CEO Michael Benkowitz - President and COO Leigh Peterson - VP, Product Development James Edgemond - CFO and Tr...
Image source: The Motley Fool. United Therapeutics Corp (NASDAQ: UTHR) Q4 2020 Earnings Call Feb 24, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: United Therapeutics Corp (UTHR) Q4 2020 Earnings Call Transcript ...
BTIG analyst Robert Hazlett puts forth a bullish case for shares of MannKind Corp. (MNKD), doubling his price target to $8.He says that a collaboration with United Therapeutics (UTHR) for Tyvaso DPI in pulmonary arterial hypertension has "transformational potential."Tyvaso DPI is a next-gener...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...